HomePASG • NASDAQ
add
Passage Bio Inc
Previous close
$0.39
Day range
$0.38 - $0.42
Year range
$0.35 - $1.69
Market cap
24.69M USD
Avg Volume
167.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.27M | -22.64% |
Net income | -12.72M | 24.07% |
Net profit margin | — | — |
Earnings per share | -0.20 | 33.33% |
EBITDA | -13.55M | 23.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 76.76M | -32.84% |
Total assets | 102.41M | -31.97% |
Total liabilities | 41.15M | 4.81% |
Total equity | 61.26M | — |
Shares outstanding | 62.15M | — |
Price to book | 0.40 | — |
Return on assets | -33.32% | — |
Return on capital | -38.51% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -12.72M | 24.07% |
Cash from operations | -8.44M | 56.73% |
Cash from investing | 13.68M | 79.97% |
Cash from financing | 47.00K | 2.17% |
Net change in cash | 5.28M | 144.49% |
Free cash flow | -4.18M | 68.80% |
About
Founded
2017
Headquarters
Website
Employees
60
